-
McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, et al.
Cannabis-Based Products for Chronic Pain : A Systematic Review. Ann Intern Med 2022.
-
Lipsyc-Sharf M, de Bruin EC, Santos K, McEwen R, et al.
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive,
Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. J Clin Oncol 2022.
-
Xian J, Parthasarathy S, Ruggiero SM, Balagura G, et al.
Assessing the landscape of STXBP1-related disorders in 534 individuals. Brain 2022;145:1668-1683.
-
Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, et al.
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A
Systematic Review and Individual Patient Data Meta-Analysis. J Clin Oncol 2022;40:1879-1891.
-
Rossini D, Antoniotti C, Lonardi S, Pietrantonio F, et al.
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus
Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for
Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III J Clin Oncol 2022.
|